C32H29F5N3NaO5
653.6 g/mol
Ingrediente ativo (API)Perigo
Elagolix sodium
CAS832720-36-2
Categoria
Ingrediente ativo (API)
Classe do Composto
Outro
Uso Principal
Matéria-prima farmacêutica
Elagolix sodium is a pharmaceutical raw material used as a gonadotropin-releasing hormone antagonist. It is primarily supplied for the manufacturing of medications indicated for endometriosis-associated pain.
pharmaceutical raw material for gonadotropin-releasing hormone antagonist productsactive pharmaceutical ingredient for research and manufacturing in women's health
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 832720-36-2
Compostos relacionados
ForteEstrutura similarSimilaridade 0.85
Ethyl 4-(((1R)-2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-1(2H)-pyrimidinyl)-1-phenylethyl)amino)butanoate
CAS832720-84-0
Elagolix intermediate
ForteEstrutura similarSimilaridade 0.85
Ethyl (R)-4-((2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl)-1-phenylethyl)amino)butanoate hydrochloride
CAS1150560-46-5
pharmaceutical intermediate
SimilarEstrutura similarSimilaridade 0.73
1,1-Dimethylethyl N-[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]carbamate
CAS830346-51-5
Pharmaceutical intermediate for elagolix
AplicaçãoMesmo uso
Linzagolix
CAS935283-04-8
gonadotropin-releasing hormone antagonist
AplicaçãoMesmo uso
Ganirelix
CAS123246-29-7
gonadotropin-releasing hormone antagonist
AplicaçãoMesmo uso
Ganirelix
CAS124904-93-4
gonadotropin-releasing hormone antagonist
AplicaçãoMesmo uso
Ganirelix acetate
CAS129311-55-3
gonadotropin-releasing hormone antagonist
ReferênciaMesma categoria
Ofloxacin
CAS83380-47-6
active pharmaceutical ingredient
Referência de Segurança
Perigo
H304May be fatal if swallowed and enters airways
H319Causes serious eye irritation
H360May damage fertility or the unborn child
H361Suspected of damaging fertility or the unborn child
Identificadores
Nome IUPAC
sodium 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoate
InChIKey
DQYGXRQUFSRDCH-UQIIZPHYSA-M
SMILES
CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)C[C@@H](C3=CC=CC=C3)NCCCC(=O)[O-])C4=C(C(=CC=C4)OC)F.[Na+]
Sinônimos (18)
- Elagolix sodium (USAN)
- 832720-36-2 (sodium)
- Elagolix sodium
- Elagolix sodium (Standard)
- Elagolix sodium salt
- NBI-56418 NA
- NBI-56418 sodium
- NBI56418; ABT-620
- Orilissa (TN)
- Orlissa